Journal article icon

Journal article

Anti-TNF therapy

Abstract:
Tumor necrosis factor (TNF) is one of the most important cytokines produced by macrophages. TNF is a very important component of host defense, released very rapidly after all types of injuries and stimuli. The kinetics of TNF release are short, and so it is perhaps not surprising that prolonged TNF production is associated with pathology. This was first elucidated in rheumatoid arthritis but extends to other chronic inflammatory diseases such as Crohn’s disease and psoriasis. In this chapter, the discovery of anti-TNF therapy is reviewed, with its benefit but also its limitations. The potential of anti-TNF therapy in other diseases, e.g., cardiovascular and fibrosis, is discussed, as is the opportunity to define ways of blocking TNF synthesis.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1128/microbiolspec.MCHD-0022-2015

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Kennedy Institute for Rheumatology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author


Publisher:
American Society for Microbiology
Journal:
Microbiology Spectrum More from this journal
Volume:
4
Issue:
4
Article number:
46
Publication date:
2016-08-12
Acceptance date:
2015-10-26
DOI:
EISSN:
2165-0497


Language:
English
Pubs id:
pubs:653569
UUID:
uuid:403abd11-9ec7-4e00-b581-204d1cbfde90
Local pid:
pubs:653569
Source identifiers:
653569
Deposit date:
2017-01-17
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP